Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bayer
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parameters
To evaluate the effect of 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) administered simultaneously with sildenafil on blood pressure in subjects with symptomatic pulmonary arterial hypertensio...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer AG
Update Il y a 4 ans
Safety, tolerability and pharmacokinetics of regorafenib in pediatric subjects
- To define the safety profile, maximum tolerated dose (MTD) and recommended phase II dose (RP2D) of regorafenib administered orally as a single agent in a 3-weeks-on / 1- week-off schedule in repeati...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Bayer AG
Update Il y a 4 ans
Phase I relative bioavailability and food effect study
The primary objectives of this study are to •investigate the relative bioavailability of a single oral dose of 20 mg finerenone suspension and 20 mg crushed and resuspended tablet in comparison to 20...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Bayer Schering Pharma AG
Update Il y a 4 ans
Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral contraceptives (OC) to alleviate complaints of reduced libido in women with acquired female sexual dysfunction (FSD) associated with OC-use
To investigate the effects of 100 mg DHEA per day in women on continuous treatment with a monophasic combined oral contraceptive (COC) who suffer from an acquired OC-associated HSDD as a perceived adv...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Double-blind, placebo controlled, randomized study of vardenafil to determine efficacy on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome ("ED-METABOLIC")
The objective of this study is to determine efficacy, tolerability and safety of vardenafil on Erectile Dysfunction (ED) in men with ED and Metabolic Syndrome.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Phase Ib / II study of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide as first-line therapy in subjects with extensive disease small cell lung cancer
Phase 1b: Safety, tolerability, pharmacokinetics, and maximum tolerated dose of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide chemotherapy. Phase II: Response rate...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Bayer
Update Il y a 4 ans
Étude FORT-1 : étude de phase 2-3 randomisée comparant l’efficacité et la sécurité d’emploi du rogaratinib avec celles d’une chimiothérapie à base de docétaxel, paclitaxel ou vinflunine chez des patients ayant un carcinome urothélial localement avancé ou métastatique positif pour le récepteur FGFR et traité précédemment par une chimiothérapie contenant du platine. [essai clos aux inclusions]
Le carcinome urothélial est le type de cancer de la vessie le plus fréquent, représentant plus de 90 % de l’ensemble des cas de cancer de la vessie. Il peut survenir dans n’importe quelle partie de l’...
Country
France
organs
Rein
,
Vessie
,
Appareil urinaire - autres
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Ekkehard Bayerdörffer, MD
Update Il y a 4 ans
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
The purpose of this study is to compare on demand with continuous treatment of endoscopy negative subjects with gastroesophageal reflux disease (GERD), with esomeprazole 20-mg once daily, ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A randomized, double-blind, double-dummy, multicenter, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediately after nerve-sparing prostatectomy for improving erectile function
The objective of this study is to compare the efficacy and safety of two modes of vardenafil therapy versus placebo to treat erectile dysfunction, starting within 14 days following bilateral nerve-spa...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Bayer
Update Il y a 4 ans
Bayer STORM : Essai de phase 3 randomisé en double aveugle, évaluant l'efficacité et la tolérance du sorafénib, en traitement adjuvant après chirurgie, chez des patients ayant un cancer du foie. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A Phase III Randomized, Double-Blind, Placebo-Controlled Study of Sorafenib as Adjuvant Treatment for Hepatocellular Carcinoma After Surgical Resection or Local Ablation.
Country
France
organs
Primitif du foie
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Previous
12
13
14
15
16
17
18
19
20
21
Next